(Q42620780)

3 November 2017

Cloning, heterologous expression and characterization of murine interleukin 1 receptor antagonist protein (English)

1 reference

https://api.crossref.org/works/10.1002/EJI.1830211119

5 December 2022

1 reference

https://api.crossref.org/works/10.1002/EJI.1830211119

5 December 2022

author name string

Shuck ME

1

1 reference

3 November 2017

Eessalu TE

2

1 reference

3 November 2017

Tracey DE

3

1 reference

3 November 2017

Bienkowski MJ

4

1 reference

3 November 2017

language of work or name

English

0 references

publication date

1 November 1991

1 reference

full work available at URL

3 November 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Feji.1830211119

1 reference

https://api.crossref.org/works/10.1002/EJI.1830211119

https://onlinelibrary.wiley.com/doi/full/10.1002/eji.1830211119

5 December 2022

1 reference

https://api.crossref.org/works/10.1002/EJI.1830211119

European Journal of Immunology

5 December 2022

published in

1 reference

3 November 2017

21

1 reference

3 November 2017

2775-2780

1 reference

3 November 2017

11

1 reference

The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response

3 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211119

7 January 2021

Characteristics of chondrocyte responses to a human interleukin 1-like factor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211119

7 January 2021

Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211119

7 January 2021

Mononuclear cell-conditioned medium containing mononuclear cell factor (MCF), homologous with interleukin 1, stimulates collagen and fibronectin synthesis by adherent rheumatoid synovial cells: effects of prostaglandin E2 and indomethacin.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211119

7 January 2021

Corticotropin-releasing activity of monokines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211119

7 January 2021

Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211119

7 January 2021

Native interleukin 1 inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211119

7 January 2021

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211119

7 January 2021

Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211119

7 January 2021

Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211119

7 January 2021

Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211119

7 January 2021

Interleukin-1 receptor antagonist reduces mortality from endotoxin shock

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211119

7 January 2021

Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211119

7 January 2021

A specific receptor antagonist for interleukin 1 prevents Escherichia coli ‐induced shock in rabbits

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211119

7 January 2021

A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211119

7 January 2021

C3 activation products correlate with antibodies to lipid A in pauciarticular juvenile arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211119

7 January 2021

Crystallization of purified recombinant human interleukin-1 beta

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211119

7 January 2021

A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211119

7 January 2021

https://api.crossref.org/works/10.1002%2FEJI.1830211119

1 reference

7 January 2021

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211119

7 January 2021

Potentiation of the T-lymphocyte response to mitogens. I. The responding cell

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211119

7 January 2021

Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211119

7 January 2021

Receptor- and heparin-binding domains of basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211119

7 January 2021

Three-dimensional structure of human basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211119

7 January 2021

Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211119

7 January 2021

Production of interleukin-1 (IL-1) and a specific IL-1 inhibitor during human monocyte-macrophage differentiation: influence of GM-CSF

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211119

7 January 2021

Identifiers

1 reference

release_g4s5xfg5lvevbm6bb4x4dgx7dy

3 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/g4s5xfg5lvevbm6bb4x4dgx7dy

24 November 2022

mapped directly with Wikidata item

1 reference